Usfda Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules webmaster Saturday, February 01, 2025
their Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S. webmaster Tuesday, December 17, 2024